1. Home
  2. VINP vs PCRX Comparison

VINP vs PCRX Comparison

Compare VINP & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

HOLD

Current Price

$9.44

Market Cap

638.8M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.92

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VINP
PCRX
Founded
2009
2006
Country
Brazil
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
638.8M
1.1B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
VINP
PCRX
Price
$9.44
$25.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$14.00
$30.25
AVG Volume (30 Days)
43.5K
416.5K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
5.72%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
N/A
$541,533,000.00
Revenue This Year
$18.07
$6.78
Revenue Next Year
$12.74
$8.54
P/E Ratio
$24.41
$136.21
Revenue Growth
N/A
26.04
52 Week Low
$9.19
$18.80
52 Week High
$13.61
$27.66

Technical Indicators

Market Signals
Indicator
VINP
PCRX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
VINP
PCRX

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: